Literature DB >> 23555412

Mortality from pulmonary heart disease in Japan, 1979-2006.

Masahito Sakuma1, Norifumi Nakanishi, Kunio Shirato.   

Abstract

OBJECTIVE: In Japan, there have been no reports on the time-trends of mortality rates from pulmonary heart disease without pulmonary embolism (PHD). Our aim was to examine the annual changes of mortality in Japan.
MATERIALS AND METHODS: Annual age-adjusted and age-specific PHD mortality for Japanese residents during 1979-2006 were calculated from "Vital statistics of Japan" and census data and population estimates for intercensal years.
RESULTS: The number of age-adjusted deaths from PHD continued to decrease throughout the study period. The age-specific mortality from PHD increased throughout the life span except below 1 year old and decreased in recent years. Male mortality was greater at most ages. In Poisson regression analysis, the relative risk of death from PHD was increased in males and the aged except below 1 year-age, and decreased in recent years. The annual number of deaths from idiopathic pulmonary arterial hypertension/heritable pulmonary arterial hypertension (IPAH/HPAH) continued to increase throughout the study period. The number of annual new cases with IPAH/HPAH was estimated to be about 400 in a recent period of 10 years.
CONCLUSION: The annual number of deaths from PHD decreased, and those from IPAH/HPAH increased significantly during 1979-2006 in Japan.

Entities:  

Keywords:  idiopathic pulmonary arterial hypertension; mortality; pulmonary circulation; pulmonary hypertension

Year:  2010        PMID: 23555412      PMCID: PMC3595786          DOI: 10.3400/avd.oa01011

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  14 in total

Review 1.  Clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Nazzareno Galiè; Lewis J Rubin; David Langleben; Werner Seeger; Guido Domenighetti; Simon Gibbs; Didier Lebrec; Rudolf Speich; Maurice Beghetti; Stuart Rich; Alfred Fishman
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

2.  Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

Authors:  Steeve Provencher; Olivier Sitbon; Marc Humbert; Ségolène Cabrol; Xavier Jaïs; Gérald Simonneau
Journal:  Eur Heart J       Date:  2006-01-23       Impact factor: 29.983

3.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.

Authors:  V V McLaughlin
Journal:  Eur J Clin Invest       Date:  2006-09       Impact factor: 4.686

6.  Pulmonary hypertension surveillance--United States, 1980-2002.

Authors:  Alexandra Hyduk; Janet B Croft; Carma Ayala; Kan Zheng; Zhi-Jie Zheng; George A Mensah
Journal:  MMWR Surveill Summ       Date:  2005-11-11

7.  Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990.

Authors:  O Okada; N Tanabe; J Yasuda; Y Yoshida; K Katoh; T Yamamoto; T Kuriyama
Journal:  Intern Med       Date:  1999-01       Impact factor: 1.271

8.  Primary pulmonary hypertension in Israel: a national survey.

Authors:  L Appelbaum; M Yigla; D Bendayan; N Reichart; G Fink; I Priel; Y Schwartz; P Richman; E Picard; S Goldman; M R Kramer
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

9.  Mortality from primary pulmonary hypertension in the United States, 1979-1996.

Authors:  D E Lilienfeld; L J Rubin
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

10.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.